RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced development progress for RHB-102 (Bekinda®) in multiple GI indications, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback